Most Recent
Cipla is opposing the extension of Novo Nordisk’s patent for its Victoza weight loss and diabetes drug, arguing extensions can only be granted for active ingredients and not entire formulations.
The Commonwealth has argued that a long-running dispute involving drug makers Otsuka, Bristol-Myers Squibb and Generic Health should be put on ice until the High Court rules in a separate matter.
AstraZeneca has brought court proceedings to block Australian drug maker Pharmacor from making a generic version of its heart attack drug Brilinta.
Green iron start-up Element Zero is continuing its fight over search orders won by rival Fortescue that it claimed were a massive over-reach.
The scope of protection for geographical indications will be at issue in India's appeal of a decision that barred it from registering a trade mark for basmati rice.
Coles has defeated a trade mark challenge to its Perform brand of sports nutrition products by a sports equipment company.
Bayer has lost its battle to protect top-selling blood thinner Xarelto from generic competition, with the Full Court finding two patents for the drug are invalid.
Infant formula company Care A2 has found new lawyers as trial begins in a trade mark dispute with rival a2 Milk.
Care A2 is set to miss the trial in its trade mark fight with rival A2 Milk after the baby formula company was ditched by its lawyers at Ashurst days ago.